Status
Conditions
Treatments
About
Remote ischemic preconditioning (RIPC) is a concept where remotely induced ischemia produces protection against ischemia-reperfusion injury in a remote organ. RIPC has been studied extensively in animal models and heart surgery, but it's benefit in transplantation has been studied less. The primary aim of this study is to find out whether RIPC performed in a donor in donation after brain-death (DBD) could improve delayed graft function rate of kidney transplants.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Donor Inclusion Criteria:
Donor Exclusion Criteria:
All organ recipients receiving organs (kidney, liver, pancreas-kidney, heart, lungs) from a randomized donor will be recruited providing that the recipient surgery is performed at Helsinki University Hospital, recipient is over 18 years old, and recipient gives written informed consent to participate in the trial.
Primary purpose
Allocation
Interventional model
Masking
496 participants in 2 patient groups
Loading...
Central trial contact
Aki Uutela, MD; Ville Sallinen, MD, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal